SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-043746
Filing Date
2024-05-15
Accepted
2024-05-15 17:01:05
Documents
62
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0204921-10q_180life.htm   iXBRL 10-Q 770732
2 CERTIFICATION ea020492101ex31-1_180life.htm EX-31.1 10167
3 CERTIFICATION ea020492101ex31-2_180life.htm EX-31.2 10120
4 CERTIFICATION ea020492101ex32-1_180life.htm EX-32.1 3165
5 CERTIFICATION ea020492101ex32-2_180life.htm EX-32.2 3162
11 GRAPHIC image_001.jpg GRAPHIC 10680
  Complete submission text file 0001213900-24-043746.txt   4742780

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnf-20240331.xsd EX-101.SCH 50841
7 XBRL CALCULATION FILE atnf-20240331_cal.xml EX-101.CAL 30380
8 XBRL DEFINITION FILE atnf-20240331_def.xml EX-101.DEF 233012
9 XBRL LABEL FILE atnf-20240331_lab.xml EX-101.LAB 416473
10 XBRL PRESENTATION FILE atnf-20240331_pre.xml EX-101.PRE 228883
66 EXTRACTED XBRL INSTANCE DOCUMENT ea0204921-10q_180life_htm.xml XML 494964
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 24952323
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)